ACADEMIC UPDATE

• New Finding Published on Ebiomedicine 2018-02-23

  Recently, the new research finding of the China-US(Henan)Hormel Cancer Institute, Losmapimod Overcomes Gefitinib Resistance in Non-small Cell Lung Cancer by Preventing Tetraploidization, was published on EBioMedicine, a well-known journal on translational medicine, co-launched by two world class academic journals, …

• Breakthrough in Colon Cancer Screening 2015-12-30

  E-BioMedicine, a translational medical journal co-sponsored by The Lancet and Cell, published an online paper co-authored by Dr. Kangdong Liu, Dr. Haitao Li from China- US (Henna) Hormel Cancer Institute and Dr. Yuzhou Zhao from Henan Cancer Hospital entitling “Circulating Prostaglandin Biosynthesis in Colorectal …